Leading the way to safer medication
 Crosscheck  Recommender

Anagrelide

Description

Anagrelide is an inhibitor of cyclic AMP phosphodiesterase III and suppress expression of transcription factors including GATA-1 and FOG-1 required for megakaryocytopoiesis, ultimately leading to reduced platelet production.

ATC Classification

Code
Title
Category
L01XX35
Anagrelide
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents

Trade names

Trade name
Countries
AGRYLIN

Canada Singapore United States

ANAGRELIDE

Austria

THROMBOREDUCTIN

Austria

XAGRID

Austria Cyprus France Netherlands Spain

XERALID

Austria

Product Monographs

Monograph
Type
Country
XAGRID Capsule
MPI, EU: SmPC
AGRYLIN Capsule
MPI, US: SPL/PLR
US

2D Molecule Structure

Unique Ingredient Identifier (UNII)

K9X45X0051 - ANAGRELIDE

CAS Registry Number

68475-42-3 - anagrelide

SNOMED-CT

372561005 - Anagrelide (substance)

 
Next: Usage >